Effect of streptozotocin-induced diabetes on rat brain mitochondria

Journal of Neuroendocrinology

Volumn 16, Issue 1, 2004, Pages 32-38

  Moreira, P I ^a   Santos, M S ^a   Moreno, A M ^a   Proenca T ^b   Seica R ^c   de Oliveira, Catarina Resende ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Brain; Cardiolipin; Glutathione; Malondialdehyde; Mitochondria; Oxidative stress; Streptozotocin; Type 1 diabetes; Vitamin E

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; CARDIOLIPIN; CITRIC ACID; GLUTATHIONE; MALONALDEHYDE; MITOCHONDRIAL ENZYME; STREPTOZOCIN; SUCCINATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MITOCHONDRION; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEMBRANE POTENTIAL; METABOLIC PARAMETERS; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPOLARIZATION; RESPIRATORY CHAIN; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES;

EID: 0742324515     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2004.1107.x     Document Type: Article

References (40)

1. Sandler S, Swenne I. Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro. Diabetologia 1983; 25: 444-447.
2. Heller B, Burkle A, Radons J, Fengler E, Jalowy A, Muller M, Burkart V, Kolb H. Analysis of oxygen radical toxicity in pancreatic islets at the single cell level. Biol Chem Hoppe-Seyler 1994; 374: 597-602.
3. Nukatsuka M, Yoshimura Y, Nishida M, Kawada J. Importance of the concentration of ATP in rat pancreatic beta cells in the mechanism of streptozotocin-induced cytotoxicity. J Endocrinol 1990; 127: 161-165.
4. Low PA, Lagerlund TD, McManis PG. Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol 1989; 31: 355-438.
5. Brownlee M, Cerami A, Vlassara H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 1988; 4: 437-451.
6. Cameron NE, Cotter MA, Jack MA, Basso MD, Hohman TC. Protein kinase C effects on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rats. Diabetologia 1999; 42: 1120-1130.
7. Greene DA, Sima AA, Stevens MJ, Feldman EL, Lattimer SA. Complications: neuropathy, pathogenetic considerations. Diabetes Care 1992; 15: 1902-1925.
8. Cameron NE, Cotter MA. Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneurial oxygen tension in streptozotocin-diabetic rats. Acta Diabetol 1994; 31: 220-225.
9. Hellweg R, Hartung HD. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus. a possible role of NGF in the pathogenesis of diabetic neuropathy. J Neurosci Res 1990; 26: 258-267.
10. Muranyi M, Masayuki F, He Q, Han A, Yong G, Csiszar K, Li PA. Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes 2003; 52: 481-486.
11. Grunnet M. Cerebrovascular disease: diabetes and cerebral atherosclerosis. Neurology 1963; 13: 486-491.
12. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH. Evidence for diabetic encephalopathy. Diabet Med 1991; 8: 162-167.
13. Fergunson SC, Blane A, Perros P, McCrimmon RJ, Best JJK, Wardlaw J, Deary IJ, Frier BM. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003; 52: 149-156.
14. Lunetta M, Damanti AR, Fabbri G, Lombardo M, Di Mauro M, Mughini L. Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J Endocrinol Invest 1994; 17: 241-245.
15. Flarsheim CE, Grupp IL, Matlib MA. Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol 1996; 271: H192-H202.
16. Berman SB, Watkins SC, Hastings TG. Quantitative biochemical and ultrastructural comparison of mitochondrial permeability transition in isolated brain and liver mitochondria: evidence for reduced sensitivity of brain mitochondria. Exp Neurol 2000; 164: 415-425.
17. Rodrigues B, Poucheret P, Battell ML, McNeill JH. Streptozotocin-induced diabetes: induction, mechanism(s), dose dependency. In: McNeill JH, ed. Experimental Models of Diabetes. Boca Raton: CRC Press, 1999: 3-14.
18. Rosenthal RE, Hamud F, Fiskum G, Varghese PJ, Sharpe S. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine. J Cereb Blood Flow Metab 1987; 7: 752-758.
19. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949; 177: 751-766.
20. Estabrook RE. Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Meth Enzymol 1967; 10: 41-47.
21. Kamo N, Muratsugu M, Hongoh R, Kobatake V. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenylphosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Memb Biol 1979; 49: 105-121.
22. Moreno AJM, Madeira VMC. Mitochondrial bioenergetics as affected by DTT. Biochem Biophys Acta 1991; 1060: 166-174.
23. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation on malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987; 33: 214-220.
24. Petit JM, Maftah A, Ratinaud MH, Julien R. 10N-Nonyl acridine interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 1992; 209: 267-273.
25. Vatassery GT, Younoszai R. Alpha tocopherol levels in various regions of the central nervous systems of the rat and guinea pig. Lipids 1978; 13: 828-831.
26. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 226-714.
27. Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002; 51: 1118-1124.
28. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
29. Reagan LP, Magarinos AM, Yee DK, Swzeda LI, Van Bueren A, McCall AL, McEwen BS. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res 2000; 862: 292-300.
30. Aragno M, Brignardello E, Tamagno E, Gatto V, Danni O, Boccuzzi G. Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats. J Endocrinol 1997; 155: 233-240.
31. Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 2003; 52: 165-171.
32. Aoki C, Milner TA, Sheu KFR, Blass JP, Pickel VM. Regional distribution of astrocytes with inense immunoreactivity for glutamate dehydrogenase in rat brain: implications for neuron-glia interactions in glutamate transmission. J Neurosci 1987; 7: 2214-2231.
33. Calingasan NY, Baker H, Sheu KF, Gibson GE. Distribution of the α-ketoglutarate dehydrogenase complex in rat brain. J Comp Neurol 1994; 346: 461-479.
34. Romero FJ, Monsalve E, Hermenegildo C, Nies E, Puertas FJ, Higueras V, Nies E, Segura-Aguilar J, Roma J. Oxygen toxicity in the nervous tissue: comparison of antioxidant defense of rat brain and sciatic nerve. Neurochem Res 1991; 16: 157-161.
35. Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV. Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 2003; 462: 67-71.
36. Skrha J, Prazny M, Hilgertova J, Weiserova H. Serum alpha-tocopherol and ascorbic acid concentrations in Type 1 and Type 2 diabetic patients with and without angiopathy. Clin Chim Acta 2003; 329: 103-108.
37. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta 1992; 1113: 71-133.
38. Schlame M, Rua D, Greenberg ML. The biosynthesis and functional role of cardiolipin. Prog Lipid Res 2000; 39: 257-288.
39. Paradies G,, Petrosillo G, Pistolese M, Ruggiero FM. The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett 2000; 466: 323-326.
40. Moreira PI, Sancha MS, Rego AC, Moreno A, Oliveira C. Effect of amyloid β-peptide on the permeability transition pore: a comparative study. J Neurosc Res 2002; 69: 257-267.